Blackrock’s Sending THIS Crypto Higher on Purpose

It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…

Jacob A. Orville net worth and biography

Jacob Orville Biography and Net Worth

Insider of Exact Sciences

Jake Orville serves as our General Manager, Pipeline. Prior to joining Exact Sciences, Mr. Orville served as General Manager, Cardiometabolic & Endocrinology Franchise at Quest Diagnostics, Inc., In 2008, Mr. Orville co-founded Cleveland HeartLab, Inc., and served as its Chief Executive Officer through 2017 when Cleveland HeartLab was acquired by Quest. Earlier in his career Mr. Orville served in leadership and operational roles at NextGen Sciences, Inc., and Third Wave Technologies, Inc. Mr. Orville holds a bachelor's degree from the University of Massachusetts-Amherst and a Master of Business Administration from the University of Wisconsin-Madison. Mr. Orville currently serves as a board member of the Wisconsin Women’s Health Foundation.

What is Jacob A. Orville's net worth?: The estimated net worth of Jacob A. Orville is at least $754,874.80 as of March 1st, 2024. Mr. Orville owns 14,324 shares of Exact Sciences stock worth more than $754,875 as of November 21st. This net worth estimate does not reflect any other assets that Mr. Orville may own. Learn More about Jacob A. Orville's net worth.
How do I contact Jacob A. Orville?: The corporate mailing address for Mr. Orville and other Exact Sciences executives is 5505 ENDEAVOR LANE, MADISON WI, 53719. Exact Sciences can also be reached via phone at (608) 284-5700 and via email at [email protected]. Learn More on Jacob A. Orville's contact information.
Has Jacob A. Orville been buying or selling shares of Exact Sciences?: Jacob A. Orville has not been actively trading shares of Exact Sciences over the course of the past ninety days. Most recently, Jacob A. Orville sold 2,154 shares of the business's stock in a transaction on Friday, March 1st. The shares were sold at an average price of $59.32, for a transaction totalling $127,775.28. Following the completion of the sale, the insider now directly owns 14,324 shares of the company's stock, valued at $849,699.68. Learn More on Jacob A. Orville's trading history.
Who are Exact Sciences' active insiders?: Exact Sciences' insider roster includes Brian Baranick (Insider), Sarah Condella (SVP), Kevin Conroy (CEO), D. Coward (Insider), Everett Cunningham (Insider), James Doyle (Director), Jeffrey Elliott (CFO), James Herriott (General Counsel), Torsten Hoof (Insider), Daniel Levangie (Director), Graham Lidgard (Insider), Jacob Orville (Insider), and Katherine Zanotti (Director). Learn More on Exact Sciences' active insiders.
Are insiders buying or selling shares of Exact Sciences?: In the last twelve months, Exact Sciences insiders bought shares 1 times. They purchased a total of 19,500 shares worth more than $1,001,325.00. In the last twelve months, insiders at the medical research company sold shares 36 times. They sold a total of 77,348 shares worth more than $4,737,043.93. The most recent insider tranaction occured on November, 13th when CEO Kevin T Conroy bought 19,500 shares worth more than $1,001,325.00. Insiders at Exact Sciences own 1.4% of the company. Learn More about insider trades at Exact Sciences.
Information on this page was last updated on 11/13/2024.

Jacob A. Orville Insider Trading History at Exact Sciences

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/1/2024	Sell	2,154	$59.32	$127,775.28	14,324
2/27/2024	Sell	1,879	$56.89	$106,896.31	11,754
2/21/2024	Sell	1,078	$61.50	$66,297.00	8,658
2/15/2024	Sell	966	$61.43	$59,341.38	7,488
5/10/2023	Sell	5,000	$80.00	$400,000.00	6,423
3/3/2023	Sell	5,000	$65.00	$325,000.00	11,423
2/28/2023	Sell	6,832	$60.29	$411,901.28	16,423
2/22/2022	Sell	1,749	$72.72	$127,187.28
2/15/2022	Sell	940	$79.55	$74,777.00
2/19/2021	Sell	1,696	$143.38	$243,172.48
2/19/2020	Sell	1,153	$100.68	$116,084.04	3,648

Jacob A. Orville Buying and Selling Activity at Exact Sciences

Exact Sciences Company Overview

Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research, and Johns Hopkins University. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.

Today's Range

Now: $52.70

$51.71

$54.17

50 Day Range

MA: $65.32

$49.33

$71.93

2 Week Range

Now: $52.70

$40.62

$79.62

Volume

2,141,771 shs

Average Volume

2,645,736 shs

Market Capitalization

$9.75 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.27

Blackrock’s Sending THIS Crypto Higher on Purpose

From Crypto 101 Media | Ad